New markers of atherogenic risk: Hemorrheological profile in children and adolescents with familiar hypercholesterolemia;Nuevos marcadores de riesgo aterogenico: Perfil hemorreologico en ninos y adolescentes con hipercolesterolemia familiar

Anales Espanoles de Pediatria

Volumn 45, Issue 4, 1996, Pages 393-397

  Dalmau Serra, J ^a,b   Vaya Montana A ^a   Martinez Silvestre M ^a   Blesa Baviera, L C ^a   Aznar Lucea, J ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

blood viscosity; children and adolescents; erythrocyte aggregation; familiar hypercholesterolemia; fibrinogen; hemorrheology; plasma viscosity

Indexed keywords

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERLIPIDEMIA; RISK FACTOR; BLOOD; COMPARATIVE STUDY; ERYTHROCYTE AGGREGATION; FEMALE; HYPERCHOLESTEROLEMIA; MALE; PRESCHOOL CHILD;

COLESTYRAMINE; FIBRINOGEN; HYPOCHOLESTEROLEMIC AGENT;

ADOLESCENT; ANTICHOLESTEREMIC AGENTS; BLOOD VISCOSITY; CHILD, PRESCHOOL; CHOLESTYRAMINE; ERYTHROCYTE AGGREGATION; FEMALE; FIBRINOGEN; HUMANS; HYPERCHOLESTEROLEMIA; MALE;

EID: 0029904619     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89(Suppl):525-584.
2. Grande Covián F. Prevención pediátrica de la aterosclerosis. An Esp Pediatr 1995; 43:87-93.
3. Ross R. The pathogenesis of atherosclerosis. An update. N Engl J Med 1986; 314:488-500.
4. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M. Lipoprotein (a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991; 66:1054-1056.
5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes II. N Engl J Med 1992; 326:310-318.
6. Barnathan ES. Has lipoprotein «little» (a) shrunk?. JAMA 1993; 270:2224-2225.
7. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-1119.
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-1155.
9. Avogaro P, Bittolo Bon G, Cazzalato G, Quinci GB. Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet 1979; 1:901-903.
10. Durrington PN, Hunt L, Ishola M, Arrol S. Apolipoproteins (a); A1 and B and parenteral history in men with early onset ischaemia heart disease. Lancet 1988; 1:1070-1073.
11. Sehayek E, Eisenber S. The role of native apolipoprotein B containing lipoproteins in atherosclerosis: cellular mechanism. Current Opinion Lipidology 1994; 5:350-353.
12. Witztum JL. Role of oxidased low density lipoprotein in atherogenesis. Br Heart J 1993; 69(Suppl):S12-S18.
13. Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical revelance Current Opinion Lipidoloy 1994; 5:422-433.
14. Berry EM. The effects of nutrients on lipoprotein susceptibility to oxidation. Current Opinion Lipidology 1992; 3:5-11.
15. Cleland JGF, Krikler DM. Modification of atherosclerosis by agents that do not lower cholesterol. Br Heart J 1993; 69(Suppl):S54-S62.
16. Motilva MB, Bretó M, Dalmau J. Vitaminas de la dieta en la prevención de arteriosclerosis: Acción antioxidante del beta-caroteno y las vitaminas E y C. Act Ped Esp 1995; 53:77-84.
17. Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 1993; 69(Suppl):S38-S41.
18. Siegel G. Ruckborn K, Schnalke F, Muller J. Endothelial dysfunction in human atherosclerotic coronary arteries. Eur Heart J 1993; 14(Suppl 1):99-103.
19. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. I. N Engl J Med 1992; 326:242-250.
20. Bilheimer D, Tuddenham E. Cardiovascular disease: hyperlipidaemia and coagulation. Current Opinion Lipidology 1991; 2:227-229.
21. Lowe GDO. Blood viscosity, lipoproteins and cardiovascular risk. Circulation 1992; 85:2329-2331.
22. Lowe GDO. Blood viscosity and cardiovascular disease. Thromb Haemostas 1992; 67:494-498.
23. Koenig W, Sund M, Ernst E, Mraz W, Hombach V, Keil U. Association between rheology and components of lipoprotein in human blood. Circulation 1992; 85:2197-2204.
24. Leonhardt H, Arntz HR, Klemens UH. Studies of plasma viscosity in primary hyperlipoproteinemia. Atherosclerosis 1977; 28:29-40.
25. Lowe GDO, McArdle B, Stromberg P, Lorimer AD, Forbes S, Prentice CR. Increased blood viscosity and fibrinolytic activity in type II hyperlipoproteinemia. Lancet 1982; 1:472-475.
26. Stoltz JF, Gaillard S, Rouselle D, Voisin P, Drowin P. Rheological study of blood during primary hyperlipoproteinemia. Clin Hemorheol 1981; 1:227-232.
27. Jay RH, Rampling MW, Betteridge DJ. Abnormalities of blood rheology in familial hypercholesterolemia: effects of treatment. Atherosclerosis 1990; 85:249-256.
28. Vayá A, Martínez M, Carmena R, Aznar J. The lipid composition of red blood cells and their hemorheological behavior in patients with primary hyperlipoproteinemia. Clin Hemorheol 1993; 13:447-457.
29. Jay RH, McCarthy SN, Rampling MW, Betteridge DJ. Blood rheology and fibrinogen in children with familial hypercholesterolemia. Atherosclerosis 1991; 91:117-121.
30. Hernández M, Castellet J, Narvaiza JL, Rincón JM, Ruiz I, Sánchez E, Sobiadillo B, Zurimendi A. Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo. Fundación F. Orbegozo. Madrid. Garsi Editorial, 1988
31. Cortner JA, Coales PM, Gallgher PR. Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr 1990; 16:514-519.
32. Guidelines for measurement of blood viscosity and erythrocyte deformability. International Committee for Standarization in Haematology. Expert panel on blood rheology. Clin Hemorheol 1986; 6:439-453.
33. Warnick GR, Abers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lip Res 1978; 19:65-76.
34. Friedewald WT, Lewy IR. Fredrichson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
35. Heuck CC, Schlierf G. Nephelometry of apolipoprotein B in human serum. Clin Chem 1979; 25:221-226.
36. Sillbermann RS, Armentront MA, Vella A, Saha AL. Macra Lp(a) for quantification of human lipoprotein (a) by enzyme-linked immunoassay. XIV International Congress of Clinical Chemistry. San Francisco, CA; 1990.
37. Schmid-Schónbein H, Volger E, Teitel P, Kiesewetter H, Daver V, Heilmann L. New hemorheological techniques for the routine laboratory. Clin Hemorheol 1983; 2:93-95.
38. Jung F, Roggenkamp HG, Schneider R, Kiesewetter H. Das Kapillarschlauch-Plasmaviskosimeter ein neues Messgerat zur Quantifizierung der Blutplasmaviskositat. Biomed Technik 1983; 28:249-252.
39. Lowe GDO. Blood rheology in arterial disease. Clin Sci 1986; 71:137-146.
40. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981; 34:464-467.
41. Seplowitz AH, Chien S, Smith FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981; 38:89-95.
42. Vayá A, Martínez M, Carmena R, Aznar J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res 1993; 72:119-126.
43. Razavian SM, Atger V, Giral M, Cambillau M, Del Pino M, Simón AC, Moatti J, Levenson J. Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. Atheroscl Thromb 1994; 14:361-366.
44. Ernst E. Plasma fibrinogen: an independent cardiovascular risk factor. J Int Med 1990; 227:365-372.
45. Pujia A, Rubba P, Spencer MP. Prevalence of plaques and stenoses detectable by echo-doppler examination in the femoral arteries of an elderly population. Atherosclerosis 1994; 105:201-208.
46. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, LLoyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.